文献速递炎症性肠病消化道肿瘤与早癌

丹麦人群克罗恩病50年随访的临床病程

The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017.
PubMed 文献 · Aliment Pharmacol Ther · 2021-09-20

该研究基于丹麦哥本哈根县1962-1987年诊断的克罗恩病人群队列,随访至2017年,中位随访33年,共373例患者。结果显示50年累计手术概率达74%,肠道及肠外癌症风险升高,全因死亡率高于对照人群(RR 1.22)。

要点

  • 50年随访中约75%克罗恩病患者需手术,多数需重复手术。
  • 克罗恩病患者肠道及肠外癌症风险较背景人群升高。
  • 全因死亡率高于对照人群(RR 1.22,95%CI 1.04-1.43)。

核心结论

  • 随访50年后,75%的克罗恩病患者曾接受手术,且多数需要重复手术。
  • 克罗恩病患者的肠道和肠外癌症风险以及全因死亡率均高于背景人群。

研究设计与样本

  • 基于丹麦哥本哈根县1962-1987年诊断的克罗恩病人群队列,随访至2017年,共纳入373例患者。
  • 手术、癌症和死亡信息来自患者档案及丹麦国家患者登记、癌症登记和死因登记,并与一般人群匹配。

主要发现

  • 中位随访33年(范围0-56年)。
  • 诊断后10、20、30、40、50年累计手术概率分别为62%(95%CI 57%-67%)、71%(95%CI 66%-75%)、72%(95%CI 67%-76%)、74%(95%CI 69%-79%)和74%(95%CI 69%-79%)。
  • 142例(54%)患者至少接受过两次手术:69例(26%)需两次手术,73例(28%)需三次或以上。
  • 克罗恩病患者肠道(小肠、直肠和肛门)及肠外(呼吸器官和皮肤)癌症风险增加。
  • 全因死亡率高于对照人群(RR 1.22,95%CI 1.04-1.43),但胃肠道癌症死亡率未升高。

临床怎么用

  • 长期随访中应关注克罗恩病患者的高手术率及重复手术风险。
  • 对克罗恩病患者需监测肠道及肠外癌症,并重视全因死亡风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few population-based studies have investigated the long-term prognosis of Crohn's disease (CD). AIM: To determine the long-term natural disease course of CD with regard to surgery, cancer and mortality in a population-based cohort followed for more than 50 years. METHODS: All patients diagnosed with CD from 1962 to 1987 in Copenhagen County, Denmark were included in a population-based cohort. Information about surgeries, cancers and mortality was collected from patient files from 1962 to 1987 and from the Danish National Patient Registry, Cancer Registry, and from the Register of Causes of Death, 1987-2017. Patients were matched with individuals from the general population. RESULTS: A total of 373 patients were followed for a median of 33 years (range: 0-56 years). The cumulative probability of surgery 10, 20, 30, 40 and 50 years after diagnosis was 62% (CI 95%: 57%-67%), 71% (CI 95%: 66%-75%), 72% (CI 95%: 67%-76%), 74% (CI 95%: 69%-79%) and 74% (CI 95%: 69%-79%), respectively. A total of 142 patients (54%) were operated upon at least twice: 69 (26%) needing two surgeries and 73 (28%) needing three or more. Patients with CD were found to be at increased risk of intestinal (small bowel, rectum and anus) and extra-intestinal (respiratory organs and skin) cancer. All-cause mortality among CD patients was higher than among controls (RR: 1.22, CI 95%: 1.04-1.43), whereas mortality due to gastrointestinal cancer was not. CONCLUSION: After 50 years of follow-up, 75% CD patients had undergone surgery, with most needing repeat surgery. The risk of intestinal and extra-intestinal cancers, as well as mortality, was higher among CD patients than the background population.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Burisch J, Lophaven S, Langholz E, et al. The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017. Aliment Pharmacol Ther. 2021. PMID: 34543457. doi:10.1111/apt.16615

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。